A. A. Lyakishev

Ethmozin, a new antiarrhythmic drug for suppressing ventricular premature complexes.

Philip J. Podrid, A. A. Lyakishev, Bernard Lown · Circulation · 1980 · 80 citations · Full text

Heart Failure, Cardiac Anaesthesia, Cardiovascular Pharmacology +18

ATHEROGENICITY OF BLOOD SERUM FROM PATIENTS WITH CORONARY HEART DISEASE

Alexander N. Orekhov, Perova Nv, Khairulla A. Khashimov et al. · The Lancet · 1986 · 74 citations

Vascular Disease, Cardiovascular Disease, Cardiology +6

Blood serum atherogenicity associated with coronary atherosclerosis. Evidence for nonlipid factor providing atherogenicity of low-density lipoproteins and an approach to its elimination.

Alexander N. Orekhov, V.V. Tertov, S. Pokrovsky et al. · Circulation Research · 1988 · 71 citations · Full text

Vascular Disease, Healthy Subjects, Pathology +19

Cardiovascular drugs and atherosclerosis: effects of calcium antagonists, beta-blockers, and nitrates on atherosclerotic characteristics of human aortic cells.

Alexander N. Orekhov, G. N. Baldenkov, V.V. Tertov et al. · PubMed · 1988 · 45 citations

Hypertension, Vascular Disease, Human Aorta +17

Extracorporeal immunoadsorption for the specific removal of lipoprotein (a) (Lp(a) apheresis): preliminary clinical data

S. Pokrovsky, A. Sussekov, O. Afanasieva et al. · Chemistry and Physics of Lipids · 1994 · 39 citations

Specific Removal, Cardiovascular Disease, Immunology +6